Sunnyvale, CA (PRWEB) March 20, 2014
Druva announced today that its public cloud deployment option for Druva inSync, the #1-ranked endpoint data protection and governance platform, has passed a review validating the company’s security and privacy controls for handling HIPAA-compliant protected health information (PHI). The review by global consulting firm KPMG coincides with a steady increase in adoption of Druva’s inSync Cloud by customers in highly regulated industries like healthcare who choose inSync to back up, remotely access, track, and share personal and electronic health information stored on any mix of laptops, desktops, tablets and smartphones.
The KPMG review was conducted in response to HITECH legislation extending HIPAA rules to third-party service providers. inSync Cloud, designed for organizations that want endpoint data backed up and maintained outside their firewall, also has received ISAE 3000 Type II certification for cloud operations; has achieved TRUSTe EU Safe Harbor certification facilitating compliance with the European Union’s Data Protection Directive; and provides all of the infrastructure security assurances associated with being hosted by Amazon Web Services.
Apria Healthcare, University of Texas Southwestern Medical Center, Pfizer, Zoetis, Shire Pharmaceuticals, and Steris/US Endoscopy are among the Druva customers with stringent compliance requirements who have opted for inSync public cloud deployments. Druva inSync can also be deployed behind the corporate firewall in on-premise, multi-node private cloud or object storage-integrated private cloud scenarios.
“One might assume that, because healthcare is such a highly regulated industry, the adoption of the social, mobile, analytics, and cloud (SMAC) technologies would be less of a priority for CIOs and technology management overall. That assumption would be wrong,” according to a new report from Forrester Research, Inc. “These disruptive technologies have huge potential to improve healthcare outcomes or at least reduce costs, and this means that security and risk pros need to be at the forefront of enabling adoption while reducing risks.” (Industry Spotlight: US Healthcare Security Budgets, Priorities, And Challenges, Forrester Research, Inc., February 19, 2014)
“We have been seeing a steady rise in public cloud deployments of our inSync platform, and KPMG’s validation of our cloud privacy and security should add an increasing comfort level for customers who need to comply with stringent regulations like those imposed by mandates like HIPAA as well as agencies like the FDA,” said Jaspreet Singh, Druva founder and CEO. “With 99.95% availability, full data redundancy, two-factor encryption key management and a full range of other protections, our inSync Cloud delivers all the benefits of a public cloud architecture along with the security needed to fulfill regulatory requirements.”
The inSync platform provides the industry-first ability to integrate automated endpoint backup, IT-managed file sharing, encryption and other data loss prevention functions, and governance capabilities for compliance and e-discovery, eliminating point solutions that would add significant IT and user overhead. It also creates a master record of all endpoint data that enables end users to access any file remotely, plus easy content recovery in the event of device loss or theft. For more information, visit http://www.druva.com/insync/.
Druva provides integrated data protection and governance solutions for enterprise laptops, PCs, smartphones and tablets. Its flagship product, inSync, empowers an enterprise's mobile workforce with backup, IT-managed file sharing, data loss prevention, and rich analytics. Deployed in public or private cloud scenarios or on-premise, inSync is the only solution built with both IT needs and end-user experiences in mind. With offices in the United States, India and the United Kingdom, Druva is privately held and is backed by Nexus Venture Partners, Sequoia Capital and Tenaya Capital. Information on Druva is available at http://www.druva.com.